Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Select Products my Month:
2021: December | November | October | September | August | July | June | May | April | March | February | January
2021: December | November | October | September | August | July | June | May | April | March | February | January
December 2021
| 12/13/2021 | GPX1 (human) (rec.) (His) | AG-40A-0150Y |
| Back |
| 11/30/2021 | Capsaicin from Capsicum annuum | CDX-C0941 |
| 11/26/2021 | New Antibodies | RevMab |
| 11/18/2021 | anti-FOXP3 (mouse), mAb (MF333F) | AG-20A-0025Y |
| 11/08/2021 | Bumetanide | AG-CR1-3543 |
| 11/08/2021 | Lipofermata | AG-CR1-3542 |
| 11/08/2021 | Recombinant Antibodies in Collaboration with Abcalis | AG-27B-6302-6335 |
| 11/08/2021 | anti-c-Myc, mAb (rec.) (9E10 improved variant) (Fc Human) | AG-27B-6301 |
| 11/08/2021 | anti-IgG (human), mAb (rec.) Multiclonal (HRP) | AG-27B-6300E |
| 11/08/2021 | anti-IgG (human), mAb (rec.) Multiclonal | AG-27B-6300 |
| Back |
| 10/29/2021 | PANoptosome Mouse Antibodies Starter Set | AG-44B-0013 |
| 10/29/2021 | PANoptosome Human Antibodies Starter Set | AG-44B-0012 |
| 10/22/2021 | anti-TLR4 (human), mAb (28H7) | IAX-400-004 |
| 10/22/2021 | anti-TLR4 (human), mAb (2E11) | IAX-400-003 |
| 10/22/2021 | anti-TLR4 (human), mAb (blocking) (22C5) | IAX-400-002 |
| 10/22/2021 | Mouse IgG1 Isotype Control (MOPC31C) (Fab) (Biotin) | ANC-278-530 |
| 10/22/2021 | anti-CD70 (human), mAb (BU69) (APC) | ANC-222-060 |
| 10/04/2021 | Isthmin-1 (human) (rec.) (His) | AG-40B-0214 |
| 10/04/2021 | Isthmin-1 (mouse) (rec.) (His) | AG-40B-0215 |
| Back |
| 09/12/2021 | anti-NLRP3/NALP3, mAb (Cryo-2) (Biotin) | AG-20B-0014B |
| 09/03/2021 | CD304 (human)-muIg Fusion Protein (preserviative free) | ANC-557-820 |
| 09/03/2021 | CD304 (human)-muIg Fusion Protein | ANC-557-020 |
| 09/03/2021 | anti-CD244 [2B4] (human), mAb (ANC244.8/8F7) (R-PE) | ANC-239-050 |
| 09/03/2021 | anti-CD244 [2B4] (human), mAb (ANC244.8/8F7) (FITC) | ANC-239-040 |
| 09/03/2021 | anti-CD244 [2B4] (human), mAb (ANC244.8/8F7) (Biotin) | ANC-239-030 |
| 09/03/2021 | anti-CD244 [2B4] (human), mAb (ANC244.8/8F7) | ANC-239-020 |
| 09/03/2021 | anti-CD18 (human), mAb (IB4) (Fab) | ANC-167-580 |
| 09/03/2021 | CD123 [IL-3Ralpha] (human)-muIg Fusion Protein (Biotin) | ANC-545-030 |
| Back |
| 08/20/2021 | SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.617.2 Variant, Delta) | AG-48B-0007 |
| 08/10/2021 | Pepstatin A methyl ester | AG-CP3-7004 |
| 08/10/2021 | H-D-Val-Leu-Lys-pNA . 2HCl | AG-CP3-0042 |
| 08/10/2021 | Talabostat . mesylate | AG-CR1-3541 |
| 08/10/2021 | Dasatinib | AG-CR1-3540 |
| 08/10/2021 | Enoxacin | AG-CR1-3539 |
| 08/03/2021 | Fc (human):FNDC4 (rec.) | AG-40B-0213 |
| 08/03/2021 | SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (B.1.617.2.1 Variant, Delta Plus) | AG-40B-0212 |
| 08/03/2021 | SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (B.1.617.2 Variant, Delta) | AG-40B-0211 |
| Back |
| 07/16/2021 | anti-April (mouse), mAb (blocking) (Centotto-1) (preservative free) | AG-20B-0083PF |
| 07/01/2021 | SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.617.1 Variant, Kappa) | AG-48B-0006 |
| Back |
| 06/29/2021 | anti-SARS-CoV-2 N Protein, mAb (rec.) (Capsi-1) (preservative free) | AG-27B-6007PF |
| 06/29/2021 | NLRP3 Inflammasome Mouse Reagents Starter Set | AG-44B-0011 |
| 06/29/2021 | NLRP3 Inflammasome Human Reagents Starter Set | AG-44B-0010 |
| 06/11/2021 | New Chemicals | Chemodex |
| 06/08/2021 | NLRP3 Inflammasome Mouse Antibodies Starter Set | AG-44B-0009 |
| 06/08/2021 | NLRP3 Inflammasome Human Antibodies Starter Set | AG-44B-0008 |
| 06/08/2021 | CA77.1 [CMA Activator] | AG-CR1-0165 |
| 06/08/2021 | SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (B.1.617 Variant, IND) | AG-40B-0209 |
| 06/08/2021 | SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) (B.1.617.1 Variant, Kappa) | AG-40B-0208 |
| 06/08/2021 | anti-IgG (rabbit), pAb (HRP) | AG-29B-0006E |
| 06/08/2021 | New Antibodies | RevMab |
| Back |
| 05/27/2021 | Merafloxacin | AG-CR1-3756 |
| 05/20/2021 | anti-CD133 (human), mAb (ANC9C5) (APC) | ANC-363-060 |
| 05/20/2021 | anti-CD133 (human), mAb (ANC9C5) (R-PE) | ANC-363-050 |
| 05/20/2021 | anti-CD133 (human), mAb (ANC9C5) (FITC) | ANC-363-040 |
| 05/20/2021 | anti-CD133 (human), mAb (ANC9C5) (Biotin) | ANC-363-030 |
| 05/20/2021 | anti-CD133 (human), mAb (ANC9C5) (preservative free) | ANC-363-820 |
| 05/20/2021 | anti-CD133 (human), mAb (ANC9C5) | ANC-363-020 |
| 05/15/2021 | Dapansutrile | AG-CR1-3535 |
| 05/15/2021 | Mubritinib | AG-CR1-3755 |
| 05/04/2021 | SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.351 Variant, SA) | AG-48B-0005 |
| 05/04/2021 | VX-745 | AG-CR1-3754 |
| 05/04/2021 | Budesonide | AG-CR1-3753 |
| 05/04/2021 | AZ 960 | AG-CR1-3752 |
| 05/04/2021 | Efavirenz | AG-CR1-3751 |
| 05/04/2021 | Rilpivirine | AG-CR1-3750 |
| 05/04/2021 | Opaganib | AG-CR1-3749 |
| Back |
| 04/09/2021 | PF-0477736 | AG-CR1-3537 |
| 04/09/2021 | SARS-CoV-2 Neutralizing Antibodies Detection Kit (P.1 Variant, Gamma) | AG-48B-0004 |
| 04/09/2021 | SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.1.7 Variant, Alpha) | AG-48B-0003 |
| 04/09/2021 | B7-H3 [CD276] (human) ELISA Kit | AG-45B-0025 |
| 04/09/2021 | SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) (P.1 Variant, Gamma) | AG-40B-0207 |
| 04/09/2021 | SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) (B.1.351 Variant, Beta) | AG-40B-0206 |
| 04/09/2021 | SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) (B.1.1.7 Variant, Alpha) | AG-40B-0205 |
| 04/09/2021 | anti-NINJ1, pAb (IN114) | AG-25B-6002 |
| Back |
| 03/30/2021 | Euphol | AG-CN2-0541 |
| 03/10/2021 | MSA-2 | AG-CR1-0164 |
| 03/05/2021 | Streptavidin | AG-35B-0014 |
| 03/05/2021 | Streptavidin (HRP) | AG-35B-0014E |
| 03/05/2021 | Streptavidin (R-PE) | AG-35B-0014R |
| 03/05/2021 | CD40L (mouse) (multimeric) (rec.) (Biotin) | AG-40B-0020B |
| 03/05/2021 | SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (B.1.1.7 Variant, UK) | AG-40B-0202 |
| 03/05/2021 | SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (B.1.351 Variant, SA) | AG-40B-0203 |
| 03/05/2021 | SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (P.1 Variant, BR) | AG-40B-0204 |
| 03/05/2021 | IL-1beta (human) ELISA Kit | AG-45B-0021 |
| 03/05/2021 | Gasdermin E (human) ELISA Kit | AG-45B-0024 |
| 03/05/2021 | PBS with EDTA Endotoxin-free (sterile) | IAX-900-004 |
| 03/05/2021 | TRIS with EDTA [TE Buffer ] (100x) Endotoxin-free (sterile) | IAX-900-005 |
| Back |
| 02/25/2021 | 17-DMAG | AG-CN2-0540 |
| 02/11/2021 | HpARI (CCP1/2) (rec.) (His) | AG-40B-0201 |
| 02/11/2021 | SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) (Biotin) | AG-40B-0195B |
| 02/11/2021 | Rabbit IgG Isotype Control | AG-35B-0013 |
| 02/11/2021 | anti-NLRC5 (mouse), pAb (IN113) | AG-25B-0038 |
| 02/01/2021 | Oleuropein | AG-CN2-0538 |
| 02/01/2021 | Oleocanthal | AG-CN2-0537 |
| 02/01/2021 | Oleacein | AG-CN2-0535 |
| 02/01/2021 | n-Dodecyl-beta-D-maltoside (high purity) | AG-CC1-0010 |
| Back |
January 2021